Approvals/TGA/MADOPAR RAPID 62.5 levodopa 50 mg and benserazide 12.5 mg dispersible tablet bottle

Approved

STANDARD

MADOPAR RAPID 62.5 levodopa 50 mg and benserazide 12.5 mg dispersible tablet bottle

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9ee4bacdc3e6126f
Product Name: MADOPAR RAPID 62.5 levodopa 50 mg and benserazide 12.5 mg dispersible tablet bottle
Artg Id: 59577
Artg Name: MADOPAR RAPID 62.5 levodopa 50 mg and benserazide 12.5 mg dispersible tablet bottle
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 1997-09-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4de4e8150a4323381a583f71065b241b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/af0acb40ee80adbd783e8ca04296cb34.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 31, 2025

Approval ID

9ee4bacdc3e6126f

Type

Standard